EU-TTG IGA AND EU-TTG IGG— 510(k) K102964
Substantially EquivalentGrifols USA, Inc.
FDA 510(k) clearance K102964 for EU-TTG IGA AND EU-TTG IGG, Substantially Equivalent on 2011-03-07. Applicant: Grifols USA, Inc.. Device class: 2.
Clearance details
- Applicant
- Grifols USA, Inc.
- Product code
- Code MVM
- Device class
- Class 2
- Regulation
- 21 CFR 866.5660
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Los Angeles, CA, US
Recent devices under product code MVM
view all- K200230 — Aptiva Celiac Disease IgG Reagent
- K193604 — Aptiva Celiac Disease IgA Reagent
- K181871 — EliA Celikey IgG Immunoassay; EliA GliadinDP IgA Immunoassay; EliA GliadinDP IgG Immunoassay
- K183313 — EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)
- K140691 — IG_PLEX CELIAC DGP PANEL
Data sourced from openFDA. This site is unofficial and independent of the FDA.